Press and Public Relations

Press and Public Relations

Press Officer and Head of Press and Public Relations (in ch.)

Dr. Sibylle Kohlstädt

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.kohlstaedt@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 02 | 18. January 2018 | by Doy/Koh

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

© Bahr/DKFZ

Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) have now found that just how big a role Myc plays is determined by a distant section of DNA that contains a cluster of gene enhancers. In certain blood cancer cells, this cluster has been altered, which affects Myc activity and thereby accelerates cancer growth and affects how the cancer responds to chemotherapy. This cluster of enhancers might therefore be a suitable target in the treatment of blood cancer. The findings are published in Nature in collaboration with the European Molecular Biology Laboratory (EMBL) and colleagues from Canada.

learn more

No. 01c3 | 15. January 2018

New research project on age-related diseases

© Karen Beate Nøsterud - norden.org, Wikipedia

The German Cancer Research Center and the Helmholtz Zentrum München will be coordinating a project called "Aging and Metabolic Programming", or AMPro for short, over the next three years. All centers of the Helmholtz Health Research Section will be involved with the aim of exploring innovative prevention and treatment approaches to age-related diseases. Of the total funding of six million euros, around 1.5 million euros will remain at the German Cancer Research Center.

learn more

No. 01c2 | 10. January 2018 | by Koh

Genetic defect makes malignant smooth muscle tumors vulnerable

Leiomyosarcoma is a cancer of the smooth muscles
© Polarlys / Wikipedia

A research team under the leadership of scientists from the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg have conducted the first comprehensive analysis of the genome of malignant smooth muscle tumors. In a high percentage of tumors, they discovered a weak spot in the genome of the cancer cells that may serve as a therapy target in the future.

learn more

Audio (in German only)

more

einblick (in German only)

Publications

Videos (in German only)

RSS-Feed

Subscribe to our RSS-Feed.

to top